Assuntos
Dermatologia/métodos , Atenção Primária à Saúde/organização & administração , Consulta Remota/métodos , Serviços de Saúde Rural/organização & administração , Dermatopatias/diagnóstico , Atitude do Pessoal de Saúde , Brasil , Comportamento do Consumidor , Dermatologia/estatística & dados numéricos , Humanos , Consulta Remota/normas , Consulta Remota/estatística & dados numéricos , Estudos RetrospectivosRESUMO
Fluoroquinolones are an important class of synthetic antibiotics and their use recently expanded with a new activity against Gram positive and anaerobics. In the literature many side effects were documented and, among them, tendinitis and subsequent tendon rupture are important causes of morbidity. The incidence is 0.14% to 0.4% but, in the kidney recipient population, the phenomenon is even more common (incidence, 12.2%-15.6%). Advanced age seems to be the most significant risk factor. Long period of hemodialysis, diabetes mellitus, hyperparathyroidism, rheumatic diseases, gout, and corticosteroids are the other predisposing factors in kidney recipients, even if they are still under discussion. All of these risk factors can create a synergistic toxicity or at least an additive effect. A case of tendinitis and a case of bilateral Achilles tendon ruptures in 2 kidney recipients are described and a brief discussion of the literature is presented.
Assuntos
Fluoroquinolonas/efeitos adversos , Falência Renal Crônica/cirurgia , Transplante de Rim/efeitos adversos , Tendinopatia/induzido quimicamente , Traumatismos dos Tendões/induzido quimicamente , Feminino , Glomerulonefrite por IGA/complicações , Humanos , Falência Renal Crônica/etiologia , Pessoa de Meia-Idade , Complicações Pós-Operatórias , Ruptura/induzido quimicamenteRESUMO
In a multicentre prospective study, 261 patients undergoing transurethral resection of the prostate (TURP) in 17 urology departments were randomised to receive lubricating jelly containing either 3% tetracaine hydrochloride, 1% lignocaine hydrochloride, or no local anaesthetic. No patient had a history of urethral instrumentation or a previous urethral stricture. After 6 months' follow-up, 25/79 patients (32%) treated with 3% tetracaine jelly developed urethral strictures, as did 4/92 patients (4%) who received 1% lignocaine and 2/90 (2%) who received the jelly without anaesthetic. It was concluded that the use of 3% tetracaine jelly is associated with a high incidence of post-TURP urethral strictures.